Table 2.
Tissue | Gene | BioGPS [15,16] | C-It [9] | HPA [20] | TiGER [11] | UniGene [13] | VeryGene [18] | Previously studied as a (tissue) cancer or benign disease serum biomarker [reference] |
---|---|---|---|---|---|---|---|---|
Colon | CEACAM7 | √ | √ | |||||
CLCA1 | √ | √ | √ | |||||
GPA33 | √ | √ | ||||||
LEFTY1 | √ | √ | ||||||
ZG16 | √ | √ | ||||||
Lung | IRX5 | √ | √ | √ | ||||
LAMP3 | √ | √ | ||||||
MFAP4 | √ | √ | ||||||
SCGB1A1 | √ | √ | √ | |||||
SFTPA2 | √ | √ | [54-56] | |||||
SFTPB | √ | √ | √ | [55] | ||||
SFTPC | √ | √ | ||||||
SFTPD | √ | √ | √ | [56] | ||||
TMEM100 | √ | √ | √ | |||||
Pancreas | AQP8 | √ | √ | |||||
CEL | √ | √ | √ | [60] | ||||
CELA2A | √ | √ | [61] | |||||
CELA2B | √ | √ | √ | √ | ||||
CELA3B | √ | √ | ||||||
CPA1 | √ | √ | √ | √ | √ | [62] | ||
CPA2 | √ | √ | √ | √ | [62] | |||
CPB1 | √ | √ | √ | √ | [63] | |||
CTRB1 | √ | √ | ||||||
CTRB2 | √ | √ | √ | |||||
CTRC | √ | √ | √ | |||||
CUZD1 | √ | √ | √ | |||||
GCG | √ | √ | √ | |||||
IAPP | √ | √ | √ | |||||
INS | √ | √ | √ | |||||
KLK1 | √ | √ | √ | |||||
PNLIP | √ | √ | √ | √ | [64] | |||
PNLIPRP1 | √ | √ | √ | |||||
PNLIPRP2 | √ | √ | √ | |||||
PPY | √ | √ | √ | |||||
PRSS1 | √ | √ | √ | √ | √ | [65] | ||
PRSS3 | √ | √ | ||||||
REG1B | √ | √ | √ | |||||
REG3G | √ | √ | √ | |||||
SLC30A8 | √ | √ | √ | |||||
SYCN | √ | √ | √ | √ | √ | [33] | ||
Prostate | ACPP | √ | √ | √ | √ | √ | [66] | |
FOLH1 | √ | √ | [67] | |||||
KLK2 | √ | √ | [68] | |||||
KLK3 | √ | √ | √ | [66] | ||||
NPY | √ | √ | ||||||
PSCA | √ | √ | ||||||
RLN1 | √ | √ | √ | √ | ||||
SLC45A3 | √ | √ | √ | √ |
aTissue-specific proteins as it applies to this table indicates protein expression was manually verified in BioGPS and/or HPA databases. HPA: Human Protein Atlas; TiGER: Tissue-specific and Gene Expression and Regulation.